Patents Represented by Attorney J. Michael Strickland
-
Patent number: 8114885Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.Type: GrantFiled: July 30, 2007Date of Patent: February 14, 2012Assignee: GlaxoSmithKline LLCInventors: Amogh Boloor, Mui Cheung, Philip Anthony Harris, Kevin Hinkle, Jeffery Alan Stafford, James Marvin Veal
-
Patent number: 7928078Abstract: The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.Type: GrantFiled: September 16, 2008Date of Patent: April 19, 2011Assignee: GlaxoSmithKline Istrazivacki Centar Zagreb D.O.O.Inventors: Mladen Mercep, Milan Mesic, Linda Tomaskovic, Marijana Komac, Boska Hrvacic, Stribor Markovic
-
Patent number: 7858626Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.Type: GrantFiled: July 30, 2007Date of Patent: December 28, 2010Assignee: GlaxoSmithKline LLCInventors: Amogh Boloor, Mui Cheung, Ronda Gayle Davis-Ward, Philip Anthony Harris, Kevin Hinkle, Christopher P. Lauderman, Robert Anthony Mook, Jr., Jeffery Alan Stafford, James Marvin Veal
-
Patent number: 7807800Abstract: 14-membered macrolide compounds such as erythromycins are provided with functional groups at the 14- and/or 15-position by providing a 14-membered aglycone template and feeding it to a strain capable of hydroxylating it at the 14 and/or 15 position. The strain may be found by screening, selected from known strains (e.g. Streptomyces eurythermus DSM 40014) or produced by genetically engineering a strain to express a cytochrome P450 enzyme.Type: GrantFiled: November 29, 2004Date of Patent: October 5, 2010Assignee: Biotica Technology LimitedInventors: Steven Gary Kendrew, Rachel E. Lill
-
Patent number: 7579334Abstract: The present invention relates to new compounds represented by Formula I: wherein M represents a macrolide subunit of the substructure II: L represents the chain of the substructure III: āX1ā(CH2)m-Q-(CH2)nāX2ā??III D represents the steroid or nonsteroidal subunit derived from steroid or nonsteroidal (NSAID) drugs with anti-inflammatory activity; The present invention relates also to pharmaceutically acceptable salts and solvates of such prepared compounds, to process and intermediates for their preparation, as well as to the improved therapeutic action and the use in the treatment of inflammatory diseases and conditions in humans and animals.Type: GrantFiled: April 22, 2004Date of Patent: August 25, 2009Assignee: GlaxoSmithKline Istrazivacki Centar ZagrebInventors: Mladen Mercep, Milan Mesic, Linda Tomaskovic
-
Patent number: 7500444Abstract: An actuation indicator that includes a drum sub-assembly, which includes a rotatable actuation indicator wheel, a rocking, ratchet pawl for rotating the indicator wheel in a set direction and a rocking mechanism for the pawl driven by a slipping clutch arrangement, is described. The slipping clutch arrangement includes a slipping clutch spring engaged at one end to a pinion of a rack and pinion assembly and at a second end to the ratchet pawl.Type: GrantFiled: June 19, 2003Date of Patent: March 10, 2009Assignee: Glaxo Group LimitedInventors: Stanley George Bonney, Peter John Brand, James William Godfrey, Paul Kenneth Rand
-
Patent number: 7446097Abstract: The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.Type: GrantFiled: January 3, 2002Date of Patent: November 4, 2008Assignee: Glaxosmithkline Istrazivacki Centar Zagreb D.O.OInventors: Mladen Mercep, Milan Mesic, Linda Tomaskovic, Marijana Komac, Boska Hrvacic, Stribor Markovic
-
Patent number: 7387121Abstract: There is provided a propellant-operable self-activating and self-returning metering valve for an aerosol container for dispensing a formulation comprising a substance in a fluid propellant contained therein. There is also provided a canister for use in a metered dose inhaler having the valve thereon.Type: GrantFiled: July 2, 2001Date of Patent: June 17, 2008Assignee: SmithKline Beechem CorporationInventor: Stephen James Harvey
-
Patent number: 7384975Abstract: The invention relates to novel compounds of the formula (I) including all their tautomers, to pharmaceutically acceptable salts and solvates thereof, to processes and reactive intermediates for the preparation thereof, and to processes and reactive intermediates for the preparation of the compounds of the formula (II) including all their stereoisomers and tautomers to the use of the compounds of the formula (II) as suitable precursors for the preparation of the compounds of the formula (I) as well as to use of the compounds of the formula (I) and of the compounds of the formula (II) as therapeutically active agents in the prophylaxis and treatment of asthma and other inflammatory diesases and conditions in humans.Type: GrantFiled: January 20, 2006Date of Patent: June 10, 2008Assignee: GlaxoSmithKline Istrazivacki Centar Zagreb d.o.o.Inventors: Mladen Mercep, Milan Mesic, Boska Hrvacic, Ivaylo Jivkov Elenkov, Ivica Malnar, Stribor Markovic, Lidija Simicic, Andreja Cempuh Klonkay, Anita Filipovic
-
Patent number: 7383837Abstract: According to the present invention there is provided an inhalation device for dispensing medicament comprising a body (150), the body being shaped for receipt of a medicament carrier (286); and an actuator (10) having a mouthpiece (20), the actuator being reversibly movable between a dispensing position and a storage position; wherein the body includes an air channel (253), and the actuator includes an air hole (225) such that the air channel communicates with the air hole when the actuator is in the dispensing position and the air channel and air hole do not communicate when the actuator is in the storage position.Type: GrantFiled: August 9, 2001Date of Patent: June 10, 2008Assignee: SmithKline Beecham CorporationInventors: Duncan Robertson, George Robusti
-
Patent number: 7383970Abstract: A valve that includes a valve body, a valve stem having a dispensing passage, and a sealing ring that contacts the valve stem is described. The sealing ring includes a flexible component and a rigid component.Type: GrantFiled: August 5, 2005Date of Patent: June 10, 2008Assignee: Glaxo Group LimitedInventor: Gregor John McLennan Anderson
-
Patent number: 7350676Abstract: Valve for an aerosol container for dispensing a suspension of a substance in a liquid propellant contained therein. The valve comprises a valve body (1) having at least one orifice (16) to allow a quantity of the suspension to pass from the container into the valve. The valve further comprises a ring (18) disposed around the valve body (1), the ring being positioned below the at least one orifice to reduce the volume of suspension that can be accommodated within the container below the at least one orifice when the container is orientated with the valve at the bottom, the ring having at least one portion of reduced axial thickness to provide a trough (19) around the valve body below the at least one orifice.Type: GrantFiled: April 15, 2005Date of Patent: April 1, 2008Assignee: SmithKline Beecham CorporationInventors: Patrick Di Giovanni, Cheryl Vanessa Rogerson
-
Patent number: 7322355Abstract: There is provided a medicament dispenser comprising a body, a medicament container and reset means for resetting a mechanical mechanism after actuation thereof, wherein the reset means comprises a reset coupling. The coupling is reversibly deformable in response to the application of non-mechanical energy thereto. The non-mechanical energy may comprise heat energy, electrical current energy, electrical field energy or magnetic field energy.Type: GrantFiled: December 8, 2000Date of Patent: January 29, 2008Assignee: Smith Kline Beecham CorporationInventors: Anthony Patrick Jones, Paul Kenneth Rand, Duncan Robertson
-
Patent number: 7214209Abstract: A dispensing apparatus for dispensing a unit dose of a pharmaceutical substance, in particular one for intranasal administration, is disclosed. The unit dose is contained in a cylinder which is moved relative to a piston to expel the contents thereof through a passage in the piston and out of a nozzle opening. The dispensing apparatus includes a case with a base part and a cover.Type: GrantFiled: April 10, 2002Date of Patent: May 8, 2007Assignee: Glaxo Group LimitedInventor: Paolo Mazzoni
-
Patent number: 7208518Abstract: The present invention relates to novel compounds of the formula (I) including all stereoisomers and tautomers thereof, to the pharmaceutically acceptable salts and solvates thereof, to the processes and reactive intermediates for their preparation and to their use in the prophylaxis and treatment of asthma and other inflammatory diseases and/or conditions in humans.Type: GrantFiled: January 23, 2006Date of Patent: April 24, 2007Assignee: GlaxoSmithKline Istrazivacki Centar Zagreb D.O.O.Inventors: Mladen Mercep, Milan Mesic, Boska Hrvacic, Ivaylo Jivkov Elenkov, Ivica Malnar, Stribor Markovic, Lidija Simicic, Andreja Cempuh Klonkay, Anita Filipovic
-
Patent number: 7168597Abstract: A metering valve that includes a valve body defining a metering chamber having an inlet valve adapted to be reversibly actuable from an open position to a closed position located at the inlet, and an outlet valve adapted to be reversibly actuable from a dispensing to a non-dispensing position located at the outlet, where the outlet valve includes an outlet valve seat adapted to be in biasable contact with an outlet valve poppet is described. Aerosol containers and inhalation devices that include such metering valves are also described, as are methods of using such inhalation devices.Type: GrantFiled: February 23, 2000Date of Patent: January 30, 2007Assignee: Smithkline Beecham CorporationInventors: Anthony Patrick Jones, Gregor John McLennan Anderson, Paul Kenneth Rand
-
Patent number: 7107986Abstract: There is provided a dispenser suitable for dispensing medicament, particularly medicament for use in the treatment of respiratory disorders. The dispenser comprises a housing having a support; a container, locatable within said housing, having an outlet, wherein said container dispenses through said outlet in response to movement of the container relative to the housing; and an actuation indicator having an indexing mechanism actuatable by movement of the container relative to the housing. A couple mechanism is provided which couples the indexing mechanism to the container to compensate for any variation in pre-actuation positionings of the indexing mechanism and container.Type: GrantFiled: June 19, 2003Date of Patent: September 19, 2006Assignee: Glaxo Group LimitedInventors: Paul Kenneth Rand, Peter John Brand, James William Godfrey
-
Patent number: 7090831Abstract: The present invention relates to novel pharmaceutical aerosol formulations comprising: (A) salmeterol xinafoate in the form of particles coated by spray-drying with at least one surfactant in the absence of any other coating excipient, in suspension in (B) a liquefied propellant gas which is 1,1,1,2,3,3,3-heptafluoro-n-propane or 1,1,1,2-tetrafluoroethane and mixtures thereof for administration particularly by the pulmonary route and to a process for preparing these formulations. It also relates to novel particles suitable for use in such formulations.Type: GrantFiled: April 13, 2000Date of Patent: August 15, 2006Assignee: SmithKline Beecham CorporationInventors: Cecile Isabelle Bonvoisin, Christophe Laroche
-
Patent number: 7077129Abstract: There is provided a dispenser comprising a body for receipt of a carrier for a composition; an exit channel definable by the body for passage of the composition to a user; a cover for the exit channel reversibly movable between a storage position in which the cover fully protects the exit channel, to an in-use position wherein the exit channel is exposed. Biasing means act on the cover when the cover is not in the in-use or storage positions, to bias the cover towards either the in-use position or the storage position.Type: GrantFiled: December 18, 2000Date of Patent: July 18, 2006Assignee: Glaxo Group LimitedInventors: Gregor John McLennan Anderson, Anthony James Taylor
-
Patent number: 7008599Abstract: A filtration assembly operable in connection with a crystal form screening workstation that provides for automated crystal form screening is disclosed. The assembly includes first and second valves, with each valve having an internal passage and first, second and third ports. A filter line is interposed between the first and second valves in fluid communication with the second port of the first valve and the second port of the second valve. A filter medium is in disposed in or at the end of the filter line and adapted to filter a drug-containing suspension flowing through the filter line. The filter medium is operable to filter fluids under both positive and negative pressure conditions.Type: GrantFiled: May 9, 2000Date of Patent: March 7, 2006Assignee: SmithKline Beecham CorporationInventors: David Leroy Carlton, Om Parkash Dhingra, David Harlan Igo, Phillip William Waters